$250 | Single User
$500 | Site License
$750 | Global License

National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-03-2018]

Published by Global Data: 13 Mar 2018 | 203636 | In Stock

Introduction

Summary

National Institute of Neurological Disorders and Stroke (NINDS), a subsidiary of National Institutes of Health is a healthcare research institute that conducts and supports research on brain and nervous system disorders. The institute’s clinical research areas include Alzheimer’s disease, brain tumors, developmental disorders stroke, epilepsy, Parkinson’s disease, traumatic brain injury, stem cell research, health disparities research, bioengineering research and autism, among others. Its activities comprise training of investigators in basic and clinical neurosciences, and seeks better understanding, diagnosis, treatment, and prevention of neurological disorders. NINDS’ serves scientists, clinicians, and the public. The Institute collaborates with other NIH components, federal agencies, and with voluntary professional and commercial organizations. NINDS is headquartered in Bethesda, Maryland, the US.

National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-03-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

    National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

    National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

    National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

    National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

    National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deal Details 11

    Partnerships 11

    ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 11

    Geneuro Enters into Agreement with National Institute of Neurological Disorders and Stroke 12

    Thrombolytic Science Enters into Agreement with National Institute of Neurological Disorders and Stroke 13

    Lixte Biotech Enters into R&D Agreement with National Institute of Neurological Disorders and Stroke 14

    Licensing Agreements 15

    Cogentis Therapeutics to Enter into Licensing Agreement with National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services 15

    National Institute of Neurological Disorders and Stroke - Key Competitors 16

    National Institute of Neurological Disorders and Stroke - Key Employees 17

    National Institute of Neurological Disorders and Stroke - Locations And Subsidiaries 18

    Head Office 18

    Recent Developments 19

    Government and Public Interest 19

    Feb 27, 2018: College of Pharmacy Granted .7 Million Toward Epilepsy Research 19

    Feb 15, 2018: Specific set of nerve cells controls seizures’ spread through brain 21

    Feb 09, 2018: BRAIN grant funds study of neurocircuitry of depression 23

    Dec 19, 2017: Protein Levels Linked to Parkinson's Gait Difficulty and Cognitive Problems 24

    Nov 06, 2017: The Wistar Institute Awarded More Than .5M in Grants to Fund Cancer & Infectious Disease Research and Training 25

    Oct 31, 2017: NIH: Study shows how memories ripple through the brain 27

    Oct 26, 2017: Scientists find a role for Parkinson’s gene in the brain 28

    Oct 23, 2017: Penn Radiology Researcher Awarded .9 Million to Help Develop First Three-Dimensional Digital Atlas of Brain Cells 29

    Oct 18, 2017: New insight into how brain cells die in Alzheimer's disease and FTD 30

    Oct 02, 2017: CU Researchers win prestigious million NIH grant for brain study 32

    Sep 20, 2017: Researchers hit the brakes on lethal brain cancers in mice 33

    Sep 20, 2017: Immune cells may heal bleeding brain after strokes 34

    Sep 07, 2017: NIH awards nearly 0 million for Autism Centers of Excellence program 36

    Aug 18, 2017: Nortis Awarded 8K NIH Phase II SBIR Fast Track Grant to Develop Living Model of Human Blood-Brain Barrier 38

    Aug 15, 2017: New .9M federal grant to fund JAX studies of microbiome’s role in multiple sclerosis 39

    Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 40

    Jun 21, 2017: Researchers uncover genetic gains and losses in Tourette syndrome 42

    Jun 20, 2017: BlackThorn Therapeutics to Receive Up to Million in NIH Blueprint Neurotherapeutics Network Funding to Advance Kappa Opioid Receptor Antagonist Program 43

    Jan 26, 2017: NIH initiates pilot grant program for innovative neurological research 44

    Appendix 48

    Methodology 48

    About GlobalData 48

    Contact Us 48

    Disclaimer 48

List Of Tables
in National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-03-2018]

List of Tables

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Key Facts 2

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

National Institute of Neurological Disorders and Stroke, Deals By Therapy Area, 2012 to YTD 2018 9

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 11

Geneuro Enters into Agreement with National Institute of Neurological Disorders and Stroke 12

Thrombolytic Science Enters into Agreement with National Institute of Neurological Disorders and Stroke 13

Lixte Biotech Enters into R&D Agreement with National Institute of Neurological Disorders and Stroke 14

Cogentis Therapeutics to Enter into Licensing Agreement with National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services 15

National Institute of Neurological Disorders and Stroke, Key Competitors 16

National Institute of Neurological Disorders and Stroke, Key Employees 17

List Of Figures, Charts and Diagrams
in National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-03-2018]

List of Figures

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

203636 | GDPH67330D

Number of Pages

48

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Lawrence Livermore National Laboratory - Medical Equipment - Deals and Alliances Profile
SummaryLawrence Livermore National Laboratory (LLNL) is a national security technology provider. The...
25 Feb 2016 by Global Data USD $250 More Info
National University of Singapore - Medical Equipment - Deals and Alliances Profile
SummaryNational University of Singapore (NUS) is an educational institution that provides education ...
25 Feb 2016 by Global Data USD $250 More Info
Centre National de la Recherche Scientifique - Medical Equipment - Deals and Alliances Profile
SummaryCentre National de la Recherche Scientifique (CNRS) is an educational center that offers rese...
24 Feb 2016 by Global Data USD $250 More Info
National HealthCare Corporation (NHC) - Financial and Strategic SWOT Analysis Review
SummaryNational HealthCare Corporation (NHC) is a health care service provider that offers home-care...
09 Jan 2016 by Global Data USD $300 More Info
National Research Corporation (NRCIB) - Financial and Strategic SWOT Analysis Review
SummaryNational Research Corporation (NRC) is a healthcare organization that provides patient-center...
09 Jan 2016 by Global Data USD $300 More Info
National HealthCare Corporation (NHC) - Financial and Strategic SWOT Analysis Review
SummaryNational HealthCare Corporation (NHC) is a health care service provider that offers home-care...
08 Nov 2015 by Global Data USD $300 More Info
National Research Corporation (NRCIB) - Financial and Strategic SWOT Analysis Review
SummaryNational Research Corporation (NRC) is a healthcare organization that provides patient-center...
08 Nov 2015 by Global Data USD $300 More Info
Lawrence Livermore National Laboratory - Medical Equipment - Deals and Alliances Profile
SummaryLawrence Livermore National Laboratory (LLNL) is a national security technology provider. The...
23 Oct 2015 by Global Data USD $250 More Info
National Cancer Institute - Medical Equipment - Deals and Alliances Profile
SummaryNational Cancer Institute (NCI), a subsidiary of National Institutes of Health is a cancer re...
23 Oct 2015 by Global Data USD $250 More Info
Institut National de la Sante et de la Recherche Medicale - Medical Equipment - Deals and Alliances Profile
SummaryInstitut National de la Sante et de la Recherche Medicale (Inserm) is a medical research inst...
16 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 13-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data